The World Health Organization recommends that, as part of the new polio endgame, a dose of inactivated poliovirus vaccine (IPV) be introduced by the end of 2015 in all countries using only oral poliovirus vaccine (OPV). Administration of fractional dose (1/5th of full dose) IPV (fIPV) intradermally may reduce costs, but its administration is cumbersome with BCG needle and syringe. We evaluated performance of two newly developed intradermal-only jet injectors and compared the immune response induced by fIPV with that induced by full-dose IPV.
The Technical Network for Strengthening Immunization Services
We are a global network of immunization professionals committed to strengthening immunization services by building relationships, sharing knowledge, coordinating activities, and aligning priorities and goals. Learn More.
Looking for an immunization resource?
Our Knowledge Hub, built and curated by TechNet members, contains thousands of key immunization resources from around the world.
Home - TechNet-21
Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba
Our community, our knowledge
6066 members
TechNet members are immunization professionals working to improve immunization services in every country and at all levels from global policy formulation and national programme management all the way to service delivery at subnational levels.
- Connect with each other and make new contacts
- Ask questions, provide answers, and share knowledge in our forum
- Join specialist groups (communities of practice)
- Track upcoming events, such as webinars, training opportunities and global events
- Browse key publications on Hot Topics curated by global experts
- Search for guidance in our Knowledge Hub
Our Partners
We are proud to work with many organizations and initiatives across the world in our efforts to help strengthen immunization services. We support the work of all immunization professionals, from both the public and private sector, from governments and international organizations to NGOs, academic institutions, companies and manufacturers. TechNet is a member of two global immunization partnerships:
Gavi Alliance’s immunization Supply Chain Steering Committee (iSC2)
Partnership of Immunization Networks
